.
Of the 129 children enrolled in the trial from across Australia with high-risk and relapsed cancers, 67% were provided with personalised treatment plans aimed at killing their unique cancer cells. For...
In a world first, Melbourne scientists have discovered a new type of anti-cancer drug that can put cancer cells into a permanent sleep, without the harmful side-effects caused by conventional cancer t...
Cancer Therapeutics CRC (CTx), a small molecule oncology drug discovery and development group partnered with some of Australia’s pre-eminent medical research institutions, is pleased to announce two...
Cancer Therapeutics CRC (CTx) is proud to announce that it received the Australian CRC Association’s (CRCA) Award for Excellence in Innovation at the annual awards dinner in Canberra on 24 May. The...
CTx Chief Executive, Dr. Warwick Tong, today announced that a majority of its current partners have chosen to reinvest their share of the recent cash distribution from CTx back into the organisation....
CTx and its commercialisation partner Cancer Research Technology (CRT) are pleased to announce a multimillion dollar licensing deal with MSD, known as Merck in the US and Canada, to develop inhibit...